Seeing Is Believing
CYTK is currently covered by 18 analysts with an average price target of $80.76. This is a potential upside of $13.94 (20.86%) from yesterday's end of day stock price of $66.82.
Cytokinetics's activity chart (see below) currently has 127 price targets and 155 ratings on display. The stock rating distribution of CYTK is 90.79% BUY and 9.21% HOLD.
Analysts average stock forecasts to be materialized ratio is 88.29% with an average time for these price targets to be met of 356.52 days.
Highest price target for CYTK is $122, Lowest price target is $41, average price target is $80.76.
Most recent stock forecast was given by SRIKRIPA DEVARAKONDA from TRUIST on 08-Apr-2024. First documented stock forecast 18-Nov-2009.
Currently out of the existing stock ratings of CYTK, 69 are a BUY (90.79%), 7 are a HOLD (9.21%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
86
$19.71 (29.73%)
86
16 days ago
2/3 (66.67%)
$11.81 (15.92%)
190
Buy
77
$10.71 (16.16%)
48
1 months 17 days ago
3/5 (60%)
$11.16 (16.95%)
241
Buy
107
$40.71 (61.41%)
107
1 months 20 days ago
4/5 (80%)
$39.32 (58.10%)
287
Buy
108
$41.71 (62.92%)
108
1 months 27 days ago
8/9 (88.89%)
$34.91 (47.76%)
256
Buy
94
$27.71 (41.80%)
94
1 months 27 days ago
38/39 (97.44%)
$20.91 (28.61%)
801
What is CYTK (Cytokinetics) average time for price targets to be met?
Which analyst has the current highest performing score on CYTK (Cytokinetics) with a proven track record?
Which analyst has the most public recommendations on CYTK (Cytokinetics)?
Which analyst is the currently most bullish on CYTK (Cytokinetics)?
Which analyst is the currently most reserved on CYTK (Cytokinetics)?